Good points Cando, sales are going backwards if you look at 2006/05 and the addition of extra strength in 2008 - it only pulled them into the same region as the 2 years previous to 2007. Speaks very loudly. Sales in the US will not go anywhere until they have drug status or can change their marketing from immune booster to cold and flu fighter.

On the studies release date, I would agree with you but only if they come out late September. If we see them out in July or August, it ain't going to be pretty for this little piggy, IMO.

Shan is still in control, no direction coming from her, rudderless IMO, and a huge huge mistake. The CFO quit, the MD&A was a rehash of the same old same old, should just copy and paste, lol. They lost money in Q2, no real explanation on the "details" - can't believe the "Buchanan Group" ads were that much money, production of the ad would have only taken a few hours, and I saw it only a few times. promotions were not "extra" ordinary in Q2 etc.

sp will drift lower until the studies, this company is rudderless and out of favor (for good reason) with the investment community and most of all, retail investors. Lawsuits, continued losses, weak management, no direction on much of anything, no news, etc..... All just my opinion, do your own due diligence. See y'all in a couple of months, big yawn........ talking about CV is as boring as watching the companies shareprice, or paint dry.

Cheers